Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Ejhaem|August 9, 2022
Adult paroxysmal cold hemoglobinuria following mRNA COVID-19 vaccinationKyohei Misawa, Hajime Yasuda, Daisuke Koyama, et al.
Hematology (Amsterdam, Netherlands)|November 15, 2024
A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia veraChiho Furuya, Yoshinori Hashimoto, Soji Morishita, et al.
Internal Medicine (Tokyo, Japan)|June 14, 2021
High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab MonotherapySakiko Harada, Jun Ando, Miki Ando, et al.
Leukemia Research Reports|June 17, 2021
Intravascular large B-cell lymphoma as a recurrence of primary central nervous system lymphoma after chemotherapy: A case reportYoko Edahiro, Tomoiku Takaku, Mario Suzuki, et al.
European Journal of Haematology|October 8, 2022
Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemiaSoji Morishita, Yoshinori Hashimoto, Chiho Furuya, et al.
Heliyon|February 5, 2024
Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemiaAyana Uchimura, Hajime Yasuda, Hiroko Onagi, et al.
International Journal of Hematology|March 30, 2017
Three cases of relapsed/refractory multiple myeloma under hemodialysis treated with panobinostat/bortezomib/dexamethasone (FVD)Yasunobu Sekiguchi, Haruko Takizawa, Tadaaki Inano, et al.
International Journal of Hematology|October 3, 2024
Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia veraKeita Kirito, Yuka Sugimoto, Akihiko Gotoh, et al.
Scientific Reports|July 2, 2025
Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometryKohjin Suzuki, Naoki Watanabe, Yutaka Tsukune, et al.
International Journal of Hematology|March 9, 2026
Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter studyTadaaki Inano, Yuka Sugimoto, Kohshi Ohishi, et al.
Pageof 3